Moringa oleifera as the potential herb medicine for neurodegenerative diseases: a narrative review

Yulia Ratna Dewi, Agian Jeffilano Barinda, Wawaimuli Arozal


Neurodegenerative diseases, such as Alzheimer's and Parkinson's, significantly burden the global older adult population. These diseases are characterized by the degeneration of nerve cells and subsequent damage, leading to the gradual loss of neurological function and subsequently affecting the quality of life of older adult people. This study explores the potential role of Moringa oleifera (MO) on neurological diseases. MO, a plant rich in bioactive compounds such as flavonoids, polyphenols, saponins, and tannins, has been proven to possess potent antioxidant effects. Oxidative stress is a primary contributor to the pathogenesis of neurodegenerative diseases, and MO can protect nerve cell damage by enhancing antioxidant activity. In the context of Parkinson's disease, MO has demonstrated the ability to reduce cataleptic symptoms and protect dopaminergic neurons, which are crucial in preventing a decline in dopamine production in the brain. In Alzheimer's disease, MO can improve memory function, reduce oxidative stress, and inhibit the activity of Acetylcholinesterase (AChE) enzymes involved in neurotransmitter dysfunction. While further research is needed to gain a deeper understanding of MO's mechanisms and more specific therapeutic potential, the existing evidence suggests that its constituents and effects hold significant promise as a natural solution for combating the effects of neurodegenerative diseases. As the number of individuals affected by these diseases continues to rise worldwide, further investigation into MO as a neuroprotective agent could pave the way for developing more effective therapies for these conditions.


anti-oxidant; medicinal plants; Moringa oleifera; neurodegenerative disease; neuroprotective

Full Text:



Andrade S, Nunes D, Dabur M, Ramalho MJ, Pereira MC, Loureiro JA. Therapeutic Potential of Natural Compounds in Neurodegenerative Diseases: Insights from Clinical Trials. Pharmaceutics. 2023;15(1).

Nichols E, Steinmetz JD, Vollset SE, Fukutaki K, Chalek J, Abd-Allah F, et al. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Heal. 2022;7(2):e105–25.

Kang S, Eum S, Chang Y, Koyanagi A, Jacob L, Smith L, et al. Burden of neurological diseases in Asia from 1990 to 2019: a systematic analysis using the Global Burden of Disease Study data. BMJ Open. 2022;12(9).

prince martin. World Alzheimer Report. 2015;

Liu YL, Gong SY, Xia ST, Wang YL, Peng H, Shen Y, et al. Light therapy: a new option for neurodegenerative diseases. Chin Med J (Engl). 2020;134(6):634–45.

Pardillo-Díaz R, Pérez-García P, Castro C, Nunez-Abades P, Carrascal L. Oxidative Stress as a Potential Mechanism Underlying Membrane Hyperexcitability in Neurodegenerative Diseases. Antioxidants. 2022;11(8).

Geon Ha Kim, Kim JE, Rhie SJ, Yoon S. The Role of Oxidative Stress in Neurodegenerative Diseases. Exp Neurobiol. 2015;24(4):325–40.

Mahaman YAR, Huang F, Wu M, Wang Y, Wei Z, Bao J, et al. Moringa Oleifera Alleviates Homocysteine-Induced Alzheimer’s Disease-Like Pathology and Cognitive Impairments. J Alzheimer’s Dis. 2018;63(3):1141–59.

Khan MF, Yadav S, Banerjee S. Review Article on Effects of Moringa on Central Nervous System. J Young Pharm. 2021;13(4):315–9.

Mulyaningsih TR, Yusuf S. Penentuan Kandungan Mineral dalam Daun Kelor dengan Analisis Aktivasi Neutron. 2018;2(1):11–6.

Ms. Shreya Talreja, Tiwari DS. A Critical Overview on Moringa oleifera. J Glob Trends Pharm Sci. 2018;5(1):1399–404.

Kou X, Li B, Olayanju JB, Drake JM, Chen N. Nutraceutical or pharmacological potential of Moringa oleifera Lam. Nutrients. 2018;10(3).

Nair D A, James TJ, Sreelatha SL, Kariyil BJ, Nair SN. Moringa oleifera (Lam.): a natural remedy for ageing? Nat Prod Res. 2021;35(24):6216–22.

Raja RR, A MS, B SV, Navyasri DM, C GS, D SG. Moringa Oleifera-An Overview. RA J Appl Res. 2016;(September 2016).

Vergara-Jimenez M, Almatrafi MM, Fernandez ML. Bioactive components in Moringa oleifera leaves protect against chronic disease. Antioxidants. 2017;6(4):1–13.

Gopalakrishnan L, Doriya K, Kumar DS. Moringa oleifera: A review on nutritive importance and its medicinal application. Food Sci Hum Wellness. 2016;5(2):49–56.

Moyo B, Masika PJ, Hugo A, Muchenje V. Nutritional characterization of Moringa (Moringa oleifera Lam.) leaves. African J Biotechnol. 2011;10(60):12925–33.

Udofia NE, Misonge OJ, Mworia M, William N, Apiri MG. Chemical Composition of Moringa oleifera Lam . and Moringa stenopetala Bac . Leaves from Kenya. Int J plant Res. 2020;10(1):1–10.

Natsir H, Wahab AW, Budi P, Dali S, Arif AR. Amino acid and mineral composition of moringa oleivera leaves extract and its bioactivity as antioxidant Amino acid and mineral composition of moringa oleivera leaves extract and its bioactivity as antioxidant.

Caicedo-Lopez LH, Luzardo-Ocampo I, Cuellar-Nuñez ML, Campos-Vega R, Mendoza S, Loarca-Piña G. Effect of the in vitro gastrointestinal digestion on free-phenolic compounds and mono/oligosaccharides from Moringa oleifera leaves: Bioaccessibility, intestinal permeability and antioxidant capacity. Food Res Int. 2019;120:631–42.

Swetha MP, Radha C, Muthukumar SP. Bioaccessibility and bioavailability of Moringa oleifera seed flour polyphenols. J Food Meas Charact. 2018;12(3):1917–26.

Grosshagauer S, Pirkwieser P, Kraemer K, Somoza V. The Future of Moringa Foods: A Food Chemistry Perspective. Front Nutr. 2021;8(November):1–9.

Madeo J. The Role of Oxidative Stress in Parkinson’s Disease. Antioxidants. 2020;03(02):1–31.

Emamzadeh FN, Surguchov A. Parkinson’s disease: Biomarkers, treatment, and risk factors. Front Neurosci. 2018;12(AUG):1–14.

Tufail M. Clinical Features and Risk Factors of Parkinson’s Disease in a Population of Khyber Pakhtunkhwa, Pakistan: A Case-Control Study. Neurodegener Dis. 2020;19(5–6):211–7.

Joy, A. E., Shyamjith, M., & Bhat KS. Acute Effect of Ethanolic Extract of Moringa oleifera on Haloperidol Induced Catalepsy in Mice Models. Drug Invent Today. 2012;4(10):543–5.

Sabrina G, Thangavelu Soundara R, Gina Rosalinda D N, Renato I, Patrick R, Placido B, et al. The Isothiocyanate Isolated from Moringa oleifera Shows Potent Anti-Inflammatory Activity in the Treatment of Murine Subacute Parkinson’s Disease. 2017;20(1).

Singh S, Singh A, Nath V, Pratap S. GC-MS analysis of ethanolic extract of Moringa oleifera leaf and its neuroprotective effect against MPTP - induced Parkinson ’ s mouse model . 2023;12(10):3075–103.

Dominguez JC, De Guzman MFP, Joson MLC, Fowler K, Natividad BP, Cruz PS, et al. Validation of AD8-Philippines (AD8-P): A Brief Informant-Based Questionnaire for Dementia Screening in the Philippines. Int J Alzheimers Dis. 2021;2021.

Kandlur A, Satyamoorthy K, Gangadharan G. Oxidative Stress in Cognitive and Epigenetic Aging: A Retrospective Glance. Front Mol Neurosci. 2020;13(March).

Sutalangka C, Wattanathorn J, Muchimapura S, Thukham-Mee W. Moringa oleifera mitigates memory impairment and neurodegeneration in animal model of age-related dementia. Oxid Med Cell Longev. 2013;2013.

Rahmath A, Rajan N, Ahamed Shahal M, Seena TP, Sreekumaran E. Neuroprotective effect of moringa oleifera in scopolamine induced cognitive impairment and oxidative stress in Wistar Albino rats. Res J Pharm Biol Chem Sci. 2015;6(4):1736–44.

Arozal W, Purwoningsih E, Lee HJ, Barinda AJ, Munim A. Effects of Moringa oleifera in Two Independents Formulation and as Neuroprotective Agent Against Scopolamine-Induced Memory Impairment in Mice. Front Nutr. 2022;9(March):1–13.

Vargas-Sánchez K, Garay-Jaramillo E, González-Reyes RE. Effects of moringa oleifera on glycaemia and insulin levels: A review of animal and human studies. Nutrients. 2019;11(12):1–19.

Deture MA, Dickson DW. The neuropathological diagnosis of Alzheimer’s disease. Mol Neurodegener. 2019;14(1):1–18.

Reubun YTA. Penghambatan Enzim Asetilkolinesterase Pada Penyakit Alzheimer Dari Ekstrak Etanol Daun Kelor (Moringa oleifera Lam.). J Farm Indones. 2021;18(1):64–73.

Nwidu L, Elmorsy E, Aprioku J, Siminialayi I, Carter W. In Vitro Anti-Cholinesterase and Antioxidant Activity of Extracts of Moringa oleifera Plants from Rivers State, Niger Delta, Nigeria. Medicines. 2018;5(3):71.

Ganguly R Guha D. Alteration of brain monoamines & EEG wave pattern in rat model of Alzheimer’s disease & protection by Moringa oleifera. Indian J Med Res. 2008;128(6):744–51.

Mahdi O, Baharuldin MTH, Nor NHM, Chiroma SM, Jagadeesan S, Moklas MAM. Chemicals used for the induction of Alzheimer’s disease-like cognitive dysfunctions in rodents. Biomed Res Ther. 2019;6(11):3460–84.

Mahaman YAR, Feng J, Huang F, Salissou MTM, Wang J, Liu R, et al. Moringa Oleifera Alleviates Aβ Burden and Improves Synaptic Plasticity and Cognitive Impairments in APP/PS1 Mice. Nutrients. 2022;14(20).



  • There are currently no refbacks.

Indexed by:



Lisensi Creative Commons

Ciptaan disebarluaskan di bawah Lisensi Creative Commons Atribusi-NonKomersial 4.0 Internasional.

Copyright of Muhammadiyah Journal of Geriatric (e issn: 2721-6837)

Powered by Puskom-UMJ